Bcl11a maintains hematopoietic stem cell function but accelerates inflammation-driven exhaustion during aging

Area of Science:

• Hematology
• Immunology
• Aging Research

Background:

• Hematopoietic stem cell (HSC) function is critical for lifelong blood and immune system health.
• HSC function declines with age, but the mechanisms remain unclear.

Purpose of the Study:

• To investigate the role of the transcription factor Bcl11a in age-related HSC dysfunction.
• To elucidate the mechanisms underlying HSC functional decline during aging.

Main Methods:

• Utilized an inducible mosaic mouse model to overexpress Bcl11a in hematopoietic cells.
• Analyzed HSC function, bone marrow (BM) inflammation, and gene expression changes in aging mice.

Main Results:

• Aging-related Bcl11a increase mitigated HSC decline but promoted IL-1β production and HSC attrition non-cell-autonomously.
• Bone marrow inflammation enhanced Bcl11a and Fc receptor (FcR) expression in HSCs, with FcR signaling driving differentiation.
• Bcl11a counteracted FcR signaling by repressing Fcer1g, but promoted IL-1β production, exacerbating HSC deterioration.

Conclusions:

• Bcl11a exhibits a dual role in aging HSCs: intrinsic preservation and extrinsic promotion of inflammation-driven dysfunction.
• Targeting IL-1β signaling or Fcer1g can mitigate age-related HSC decline.
• Understanding Bcl11a's complex role is crucial for developing interventions for age-related hematological disorders.